SLC25A3
Basic information
Region (hg38): 12:98593591-98606379
Previous symbols: [ "PHC" ]
Links
Phenotypes
GenCC
Source:
- cardiomyopathy-hypotonia-lactic acidosis syndrome (Supportive), mode of inheritance: AR
- cardiomyopathy-hypotonia-lactic acidosis syndrome (Limited), mode of inheritance: AR
- cardiomyopathy-hypotonia-lactic acidosis syndrome (Strong), mode of inheritance: AR
- mitochondrial disease (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial phosphate carrier deficiency | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Musculoskeletal; Neurologic | 17273968 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 35 | 40 | ||||
missense | 51 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 4 | 3 | 1 | 8 | ||
non coding | 13 | 42 | 16 | 72 | ||
Total | 2 | 4 | 68 | 79 | 18 |
Highest pathogenic variant AF is 0.0000132
Variants in SLC25A3
This is a list of pathogenic ClinVar variants found in the SLC25A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-98593625-G-C | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 13, 2018) | ||
12-98593653-G-A | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Benign/Likely benign (Jul 15, 2018) | ||
12-98593667-G-A | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Benign (Jan 12, 2018) | ||
12-98593671-C-T | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Likely benign (Jan 13, 2018) | ||
12-98593676-G-A | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 13, 2018) | ||
12-98593684-G-T | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 12, 2018) | ||
12-98593707-C-G | not specified | Benign (Jan 08, 2013) | ||
12-98593707-C-T | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 12, 2018) | ||
12-98593757-C-A | not specified | Likely benign (Dec 30, 2016) | ||
12-98593760-C-T | not specified | Likely benign (Oct 13, 2017) | ||
12-98593954-C-T | not specified | Likely benign (Oct 24, 2017) | ||
12-98593968-C-T | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 13, 2018) | ||
12-98593982-T-C | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jan 12, 2018) | ||
12-98593984-C-G | Uncertain significance (Jun 30, 2022) | |||
12-98593987-G-A | Likely benign (Sep 19, 2023) | |||
12-98593989-C-T | Uncertain significance (Nov 08, 2022) | |||
12-98593996-G-A | Likely benign (Dec 11, 2023) | |||
12-98593999-C-T | Likely benign (May 03, 2022) | |||
12-98594000-C-G | Uncertain significance (May 13, 2022) | |||
12-98594000-C-T | Likely benign (Oct 05, 2023) | |||
12-98594014-C-A | Uncertain significance (Apr 06, 2022) | |||
12-98594014-C-T | Likely benign (Mar 08, 2023) | |||
12-98594016-C-T | Uncertain significance (Aug 02, 2016) | |||
12-98594027-C-G | Cardiomyopathy-hypotonia-lactic acidosis syndrome | Uncertain significance (Jun 02, 2023) | ||
12-98594028-C-T | Uncertain significance (Nov 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A3 | protein_coding | protein_coding | ENST00000228318 | 7 | 8578 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0748 | 0.923 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.24 | 155 | 205 | 0.756 | 0.0000106 | 2340 |
Missense in Polyphen | 44 | 75.514 | 0.58267 | 908 | ||
Synonymous | 0.369 | 71 | 75.1 | 0.946 | 0.00000375 | 739 |
Loss of Function | 2.68 | 5 | 16.9 | 0.296 | 8.82e-7 | 201 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transport of phosphate groups from the cytosol to the mitochondrial matrix. Phosphate is cotransported with H(+). May play a role regulation of the mitochondrial permeability transition pore (mPTP).;
- Disease
- DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- C-MYB transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.227
Intolerance Scores
- loftool
- 0.359
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.302
- hipred
- N
- hipred_score
- 0.427
- ghis
- 0.612
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.823
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a3
- Phenotype
- skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype;
Gene ontology
- Biological process
- phosphate ion transmembrane transport;proton transmembrane transport
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;integral component of mitochondrial inner membrane;myelin sheath;extracellular exosome
- Molecular function
- inorganic phosphate transmembrane transporter activity;phosphate:proton symporter activity;protein-containing complex binding